Structure via PubChem · Public domain (PubChem)
Chemical data
- Formula
- C18H26N2O4
- Molecular weight
- 334.4 g/mol
- IUPAC name
- 4-benzamido-5-(dipropylamino)-5-oxopentanoic acid
- SMILES
- CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1
- InChIKey
- DGMKFQYCZXERLX-UHFFFAOYSA-N
- XLogP
- 2.4
- Polar surface area
- 86.7 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
Withdrawn- Max clinical phase
- Approved
- Molecule type
- Small molecule
- Indications
- Peptic ulcer, gastroesophageal reflux disease, non-alcoholic steatohepatitis, cirrhosis of liver
via ChEMBL · EBI
Research
954 papers- Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome.International journal of molecular sciences · 2022
- Isobolographic Analyses of Proglumide-Celecoxib Interaction in Rats with Painful Diabetic Neuropathy.Drug development research · 2017
- Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats.The American journal of physiology · 1987
- Proglumide analogues: potent cholecystokinin receptor antagonists.The American journal of physiology · 1985
- Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma.International journal of molecular sciences · 2023
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 334.189257
Show 3 more facts
- chemical formula
- C₁₈H₂₆N₂O₄
- canonical SMILES
- CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1
- Commons category
- Proglumide
via Wikidata · CC0